Cardiovascular disease (CVD) mortality increased by 78%, rising from 72.4 to 128.7 per 100 000 (2017–2022), with the greatest ...

For patients with acute MI at increased risk for HF, empagliflozin showed cardiorenal benefits and was safe to initiate early ...

CorFlow Therapeutics is set to initiate a pivotal trial of its CorFlow CoFl system across US hospitals for heart attack.

Exposure to light at night disrupts circadian rhythms, increasing risk of heart disease, stroke, and irregular heartbeat, ...

Ghana's medical community is in mourning following the sudden and heartbreaking death of Dr. Kwame Adu Ofori, a 47-year-old ...

Health Minister says all corporate and private companies will be directed to mandatorily provide annual health screening for ...

What is the main cause of myocardial infarction A cardiologist explains how atherosclerosis and blood clots trigger heart ...

When discussing heart health, the words 'myocardial infarction' and 'heart attack' are used interchangeably as if they are ...

Flinders Health and Medical Research Institute researchers, along with colleagues in the UK and U.S., have linked brighter ...

Background It is widely believed that cardiac rehabilitation following acute myocardial infarction (MI) reduces mortality by approximately 20%. This belief is based on systematic reviews and ...

Despite the global implementation of clinical algorithms designed to predict atherosclerotic cardiovascular disease based on ...

Individuals with IBD, especially CD, have an increased risk for myocardial infarction, ischemic heart disease, cerebrovascular accident, and major adverse cardiovascular events.